Combination therapy with transcranial magnetic stimulation and ketamine for treatment-resistant depression: A long-term retrospe
Author(s) -
Steve Best,
Dan G. Pavel,
Natalie Haustrup
Publication year - 2020
Publication title -
brain stimulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.685
H-Index - 81
eISSN - 1935-861X
pISSN - 1876-4754
DOI - 10.1016/j.brs.2020.06.067
Subject(s) - transcranial magnetic stimulation , treatment resistant depression , ketamine , medicine , clinical global impression , depression (economics) , antidepressant , confidence interval , anesthesia , randomized controlled trial , stimulation , placebo , macroeconomics , economics , alternative medicine , pathology , hippocampus
Apathy (A) P roblems with initiation, psychomotor retardation, spontaneity, drive, persistence, loss of energy and interest, lack of concern about self-care and/or blunted affective expression. Disinhibition (D) P roblems with inhibitory control such as impulsivity, hyperactivity, socially inappropriate behavior and poor conformity to social conventions. Executive Dysfunction (E) P o roblems with sustained attention, working memory, rganization, planning, future orientation, sequencing, problem solving, insight, mental flexibility, self-monitoring of ongoing behavior and/or the ability to benefit from feedback or modify behavior following errors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom